Topics

zinc

nutraceuticals
Case Report: Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
COVID-19: Poor outcomes in patients with zinc deficiency
Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Low zinc levels at clinical admission associates with poor outcomes in COVID-19
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
Zinc supplementation and COVID-19 mortality: a meta-analysis
Zinc treatment of outpatient COVID-19: A retrospective review of 28 consecutive patients
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
1026